Valiant Co

Valiant Co Equity Growth

The Year-over-Year Equity Growth of Valiant Co (002643.SZ) as of Nov 19, 2026 is 1.79 %. In the previous year, Year-over-Year Equity Growth was 0.24 % — a change of 636.83% (higher).

Equity Growth

1.79 %

YoY

636.83%

Last updated:

Year-over-Year Equity Growth of Valiant Co is 2025 1.79 % . Year-over-Year Equity Growth of Valiant Co was 2024 0.24 % . It decreases by 636.83% higher compared to the previous year.

The Valiant Co Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
9.17 CNY
Jan 1, 2019
8.66 CNY
Jan 1, 2020
7.15 CNY
Jan 1, 2021
8.72 CNY
Jan 1, 2022
11.99 CNY
Jan 1, 2023
11.23 CNY
Jan 1, 2024
0.24 CNY
Jan 1, 2025
1.79 CNY
The Valiant Co Equity Growth history
YEAREquity GrowthYoY
1.79 %+636.83%
0.24 %-97.83%
11.23 %-6.35%
11.99 %+37.40%
8.72 %+21.99%
7.15 %-17.38%
8.66 %-5.61%
9.17 %+66.02%
5.52 %-88.62%
48.56 %-45.04%
88.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Co Stock analysis

What does Valiant Co do? Valiant Co., Ltd. generates revenue through three core business segments. The Information Materials Industry segment produces and sells display materials and functional materials, targeting customers in the electronics and manufacturing sectors. The Environmental Protection Materials Industry segment develops and manufactures new zeolite environmental protection materials for tail gas purification, serving automotive and industrial clients requiring emission control solutions. The Large Health Industry segment focuses on pharmaceutical production, life sciences, and in vitro diagnostic services, catering to healthcare providers and medical facilities. The company's products include display materials, functional materials, new zeolite environmental protection materials, pharmaceuticals, and in vitro diagnostic services. These offerings are sold across the three industry segments, with the Environmental Protection Materials segment specifically addressing tail gas purification needs. The Large Health Industry segment's in vitro diagnostic services support healthcare operations through specialized medical solutions. Valiant Co., Ltd. serves diverse customer segments including electronics manufacturers, automotive industries, industrial emission control clients, and healthcare providers. The firm's revenue streams are derived from the sale of physical products like display materials and zeolite materials, as well as service-based offerings in diagnostics and pharmaceuticals. The company's business model relies on manufacturing and selling these products across its three operational segments. Valiant Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Co stock

Year-over-Year Equity Growth of Valiant Co is 1.79 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Valiant Co since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Valiant Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Valiant Co

All Key Metrics — Valiant Co